Hartree Partners’s Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share IBER.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-642,500
Closed -$12.8K 67
2022
Q4
$12.8K Hold
642,500
0.01% 45
2022
Q3
$51.4K Buy
+642,500
New +$68.7K 0.04% 30

Other funds holding IBER.WS